Variables Control (n=96) ESRD  (n=96) P
Age (Years) 46(30-70) 50(30-70) 0.4a
Sex (M/F), n (%) 60/36 (62.5/37.5%) 57/39 (59.38/40.62%) 0.657b
Hemodialysis Duration (Months) NA 35.50 (7-108)
eGFR (ml/min/1.73 m2) 99.8 (90.01-129.04) 7.007(2.86-14.09) <0.001a
Creatinine (mg/dl) 0.8(0.6-1) 7.69(4.2-14.5) <0.001a*
Urea (mg/dl) 22.80(15.4-39.22) 104.77(51.14-186.9) <0.001a*
Total Cholesterol (mg/dl) 167.2838 (117.0-210) 154.83 (103.23-332) 0.150a
Triglyceride (mg/dl) 125.50 (62.86-152) 151.76 (91.06-366.6) <0.001a*
HDL-C (mg/dl) 41.17(27.94-62) 32.58(20.59-60.20) <0.001a*
VLDL-C (mg/dl) 25.10 (12.57-30.40) 30.3532 (18.21-73.33) <0.001a*
LDL-C (mg/dl) 105.006(33.8-152.2) 84.21(21.26-255.1) 0.087a
Systolic BP (mm Hg) 120 (90-135) 150 (110-190) <0.001a*
Diastolic BP (mm Hg) 70 (55-85) 90 (65-100) <0.001a*
Data are presented as median (range).
aMann-Whitney test.
bChi-square test.
*Statistically significant compared with control at P<0.05.
eGFR estimated glomerular filtration rate.
NA Not applicable.
Table 2: Clinical and biochemical characteristics of ESRD patients and controls.